CLINICAL_TRIALS
trial_result
· 2012-10-05
Clinical Trial Update: S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery [Phase 2]
Summary
A Phase 2 trial evaluating suramin for stage III or stage IV adrenocortical carcinoma unresectable by surgery was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Adrenocortical Carcinoma | Phase 2 | Status: TERMINATED